Massive Bio and the Esophageal Cancer Action Network (ECAN) are joining forces to host an informative webinar on ‘Personalized Clinical Trial Matching Service’. This significant event is slated for Tuesday, July 25, 2023, at 12:15 pm Eastern Time.
Joining the panel of experts as a distinguished guest is Dr. Arturo Loaiza Bonilla, the co-founder and Chief Medical Officer of Massive Bio. Arturo will share his extensive knowledge on the intricacies of clinical trials, aiming to simplify the process for patients seeking suitable clinical trials for esophageal, gastroesophageal, and GE junction cancers.
The webinar forms a crucial part of a collaboration between Massive Bio and ECAN. Together, they aim to launch a free, AI-driven Clinical Trial Matching Service, which will be a game-changer for patients navigating the complex landscape of clinical trials.
This joint initiative between Massive Bio and ECAN strives to make cutting-edge cancer treatments accessible to everyone, regardless of location or financial status. Their mission is to ensure that the highest quality healthcare and the opportunity to participate in relevant clinical trials is a fundamental right, not a privilege.
In addition to a comprehensive introduction to the Clinical Trial Matching Service, the webinar will host a Q&A session. This offers attendees the chance to pose their questions directly to Dr. Bonilla and other experts, giving them a deeper understanding of the service, its potential benefits, and how it can help those battling cancer.
Be sure to seize this opportunity to gain insights from industry expert Dr. Arturo Loaiza Bonilla. Let’s work together to make clinical trials more accessible and personalized, transforming cancer treatment options for patients everywhere.
For more information and to register for the webinar, please visit the ECAN website. Let’s join hands to make world-class cancer treatment universally accessible.
Webinar Information;
Tuesday, July 25, 2023
12:15 pm Eastern Time.
